Heredodegenerative Disorders, Nervous System: Clinical Trials

3 trials for Heredodegenerative Disorders, Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Suspended 3
Phase 11Suspended 1

Follow Heredodegenerative Disorders, Nervous System: new trials by email Literature Review of Heredodegenerative Disorders, Nervous System trials Research Report on Heredodegenerative Disorders, Nervous System

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Psilocybin, 1.5 mg - Fragile X Syndrome, Behavior
Phase 2SuspendedNova Mentis Life Science Corp102023-03-282024-05-08
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2SuspendedCuris, Inc.3662020-07-062026-03-19
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
STX107 - Fragile X Syndrome
Phase 2SuspendedSeaside Therapeutics, Inc.162011-05-012012-12-20

Narrower conditions

Fragile X Syndrome (2)  ·  Behavior (1)  ·  Cognitive Dysfunction (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Neurobehavioral Manifestations (1)  ·  Recurrence (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Nervous System Diseases (3)  ·  Chromosome Disorders (2)  ·  Genetic Diseases, X-Linked (2)  ·  Intellectual Disability (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sex Chromosome Disorders (2)  ·  X-Linked Intellectual Disability (2)  ·  Bone Marrow Diseases (1)  ·  Cognition Disorders (1)  ·  Disease Attributes (1)

Interventions

CA-4948 (1)  ·  Psilocybin (1)  ·  venetoclax (1)

Sponsors

Curis, Inc. (1)  ·  Nova Mentis Life Science Corp (1)  ·  Seaside Therapeutics, Inc. (1)

Countries

United States (2)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

David Crowley, MD (1)  ·  Marvin Hausman, MD (1)